Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Blood Cells Mol Dis ; 42(1): 57-63, 2009.
Article in English | MEDLINE | ID: mdl-18842429

ABSTRACT

The World Health Organization classification of mature T-cell lymphoproliferative disorders, combines clinical, morphological and immunophenotypic data. The latter is a major contributor to the classification, as well as to the understanding of the malignant T-cell behavior. The fact that T-cell migration is regulated by chemokines should, in theory, enable us to identify tissue tropism and organ involvement by neoplastic T-cells by monitoring chemokine receptor surface expression. To address this issue we compared the expression of several early and late inflammatory, homeostatic, and organ specific chemokine receptors on blood T-cells from normal individuals and patients with T-cell large granular lymphocytic leukemia and peripheral T-cell lymphoma. T-cell large granular lymphocytic leukemia cells mainly express late inflammatory chemokine receptors (CXCR1 and CXCR2), whereas peripheral T-cell lymphoma cells usually express one or more organ homing receptors (CCR4, CCR6 and CCR7). Nevertheless, no clear correlation was found between CCR4 and CCR7 expression and skin and lymph node involvement, respectively. Compared to their normal counterparts, lymphoma T-cells displayed an exaggerated CCR4 expression, whereas leukemic T-cells had abnormally high CXCR1 and CXCR2 expression. Further analysis revealed that, in leukemia patients, the percentage of neoplastic cells expressing CCR5 correlates directly with lymphocytosis. In addition, in the case of CD8 T-cell leukemia patients, an inverse correlation with neutropenia was found. In lymphoma patients, higher CCR4 and CCR7 expression is accompanied by lower to absent CCR5 expression.


Subject(s)
Leukemia, T-Cell/classification , Leukemia, T-Cell/diagnosis , Lymphoma, T-Cell/classification , Lymphoma, T-Cell/diagnosis , Receptors, Chemokine/immunology , T-Lymphocyte Subsets/immunology , Cytokines/immunology , Humans , Leukemia, T-Cell/immunology , Lymphoma, T-Cell/immunology , Receptors, Chemokine/analysis , T-Lymphocyte Subsets/pathology
2.
Am J Hematol ; 69(2): 95-102, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11835344

ABSTRACT

We have analysed, at the hematological and molecular level, 51 Hb lepore heterozygotes and three compound heterozygotes for Hb Lepore and HbS (HbLep/HbS) in 26 unselected Portuguese families. The Lepore Boston variant was present in one family, in association with classical haplotype V. All of the other Lepore alleles present haplotype III in association with XmnI (+)5' of (G)gamma gene, in tight linkage disequilibrium to the major mutation found in the Portuguese population, the Lepore Baltimore variant ( delta(68Leu)-beta(84Thr)). The three compound heterozygotes are the first HbLep/HbS individuals reported in the literature, with the Lepore Baltimore mutation linked to haplotype III. In agreement with other studies, these Lepore Baltimore heterozygotes have higher HbF (1.4-14.1% of total hemoglobin) than published cases of Lepore Boston (0.8-5.4%), which is associated with XmnI(-). Among the Lepore Baltimore heterozygotes, the (AT)xTy repeat region at -540 bp of the beta globin gene in trans to the Lepore chromosome, can account for much of the variability in HbF level. The allele (AT)7T7 is associated with lower HbF, and (AT)9T5 is associated with higher HbF. As we previously reported for beta thalassemic carriers, we observe in Lepore Baltimore carriers an effector in trans, linked to the (AT)xTy sequence, acting as an HPFH (Hereditary Persistence of Fetal Hemoglobin) determinant.


Subject(s)
Fetal Hemoglobin/analysis , Globins/genetics , Hemoglobin, Sickle/genetics , Hemoglobins, Abnormal/genetics , Heterozygote , Mutation , Adolescent , Adult , DNA/analysis , DNA Restriction Enzymes/metabolism , Haplotypes , Hemoglobin A2/analysis , Humans , Linkage Disequilibrium , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Sickle Cell Trait/blood , Sickle Cell Trait/complications , Sickle Cell Trait/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...